Insider Trading Activity Keryx Biopharmaceuticals (NASDAQ:KERX) – COO Sold 9,048 shares of Stock

ME Staff
-
0

Insider Trading Activity For Keryx Biopharmaceuticals (NASDAQ:KERX)

Christine A. Carberry , COO of Keryx Biopharmaceuticals (NASDAQ:KERX) reportedly Sold 9,048 shares of the company’s stock at an average price of 4.87 for a total transaction amount of $44,063.76 SEC Form

Insider Trading History For Keryx Biopharmaceuticals (NASDAQ:KERX)

  • On 10/3/2012 James F Oliviero III, CFO, sold 4,973 with an average share price of $2.72 per share and the total transaction amounting to $13,526.56.
  • On 5/13/2013 James F Oliviero III, CFO, sold 29,363 with an average share price of $8.34 per share and the total transaction amounting to $244,887.42.
  • On 7/5/2013 Ron Bentsur, CEO, sold 2,440 with an average share price of $7.95 per share and the total transaction amounting to $19,398.00.
  • On 7/5/2013 James F Oliviero III, CFO, sold 1,438 with an average share price of $7.95 per share and the total transaction amounting to $11,432.10.
  • On 10/3/2013 Ron Bentsur, CEO, sold 2,505 with an average share price of $10.25 per share and the total transaction amounting to $25,676.25.
  • On 10/3/2013 James Oliviero III, CFO, sold 1,475 with an average share price of $10.25 per share and the total transaction amounting to $15,118.75.
  • On 12/30/2013 James Oliviero III, CFO, sold 109,500 with an average share price of $12.64 per share and the total transaction amounting to $1,384,080.00.

    • Analyst Ratings History For Keryx Biopharmaceuticals (NASDAQ:KERX)

    Recent Trading Activity for Keryx Biopharmaceuticals (NASDAQ:KERX)
    Shares of Keryx Biopharmaceuticals closed the previous trading session at 5.06 up +0.20 4.22% with 5.130000114440918 shares trading hands.